Supraventricular tachycardia in children

Area of Science:

• Pediatric Cardiology
• Electrophysiology
• Arrhythmology

Background:

• Paroxysmal supraventricular tachycardia (PSVT) in children involves diverse mechanisms and age-specific presentations.
• Congenital atrioventricular bypass tracts cause atrioventricular reentry tachycardia, common across all ages.
• Infantile PSVT may manifest as ectopic atrial tachycardia or atrial flutter, while atrioventricular node reentry tachycardia is more prevalent in adolescence.

Purpose of the Study:

• To review the current diagnostic and management strategies for pediatric paroxysmal supraventricular tachycardia.
• To outline age-specific etiologies and treatment considerations for PSVT in infants, children, and adolescents.

Main Methods:

• Literature review of diagnostic approaches and therapeutic interventions for pediatric PSVT.
• Analysis of current treatment guidelines, including medical management and catheter ablation.
• Discussion of risk stratification for sudden death and syncope in pediatric PSVT patients.

Main Results:

• Many pediatric PSVT cases are asymptomatic and require no treatment; treatment decisions are guided by symptom severity and quality of life.
• Infants and patients with Wolff-Parkinson-White syndrome or significant heart disease require medical management due to risks of heart failure and sudden death.
• Catheter ablation is the preferred treatment for symptomatic PSVT in school-aged children and some infants refractory to medical therapy.

Conclusions:

• PSVT management in children is individualized, balancing the need for intervention against the risks of treatment.
• Advances in catheter ablation offer safe and effective treatment options for pediatric PSVT.
• A comprehensive understanding of PSVT mechanisms and tailored management strategies are crucial for optimizing outcomes in pediatric patients.